Three specialist divisions working together to take your product from early concept through development, regulation and manufacture to market.
From initial concept to commercial product, our divisions cover every stage of the diagnostic and device lifecycle.
From lateral flow and ELISA to clinical trials and contract manufacturing, we develop, validate and produce rapid diagnostic tests at scale.
Explore Diagnostics →
Accredited laboratory services supporting your product through development and post-market, from shelf life to method validation.
Explore Analytical →
Expert guidance on CE/UKCA marking, IVDR compliance and quality management systems for IVDs and medical devices.
Explore AI & MedTech →
Abingdon Health is a global developer, manufacturer and regulatory services provider specialising in lateral flow technology. Operating as both a CRO and CDMO, we offer an integrated service that takes your product from concept to commercialisation.
We are passionate about improving life by making rapid results accessible to all. Our promise is simple: working together with integrity, building long-lasting, transparent partnerships with our customers, technology partners and colleagues.
Our ambition is to deliver real-world positive change by being a leading provider of global MedTech CDMO, CRO and regulatory services, bridging the gap between diagnostic and device innovation and real-world impact.
Fast-tracking diagnostics and devices to improve lives
We are committed and honest in all that we do. We value quality and the contribution of all, and pride ourselves on building trust-based partnerships.
A closer look at how our three divisions have taken client programmes from early concept to commercial reality.
Diagnostics
Abingdon Health is proud to partner with VenomAid Diagnostics in developing a rapid snakebite diagnostic to bring life-saving care to neglected populations worldwide.
Read case study →
Diagnostics
Abingdon Health is proud to partner with 4TEEN4 Pharmaceuticals in developing a first-of-its-kind companion diagnostic for treating life-threatening shock.
Read case study →
Diagnostics
Abingdon Health partnered with SPARK at Stanford to develop a proof of concept for a novel molecular diagnostic platform.
Read case study →News, case studies and technical resources from across our three divisions.
Analytical
Article
Learn how ISO/IEC 17025 accreditation supports reliable testing, method validation and regulatory confidence for medical devices and diagnostics.
Diagnostics
Guide
Compostable, seaweed-based housings for lateral flow tests: equivalent performance on the same production lines, with no plastic.
Analytical
News
York, UK and Madison, WI, USA, 29 September 2026: Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer,…
With facilities across the UK and the United States, we support clients worldwide.
Group headquarters, manufacturing and development. Home to our clean room production facilities and core R&D operations.
UKAS-accredited analytical laboratory providing stability studies, method validation and regulatory testing services.
US operations and client support, serving the North American diagnostics and medical device market.
Whether you need development, analytical testing or regulatory support, our team is ready to help.
